Home › Funds › ARS Investment Partners, LLC › JNJ

ARS Investment Partners, LLC position in JNJ

JOHNSON & JOHNSON · Health Care

ARS Investment Partners, LLC reported holding 58,564 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$15.5M, representing 0.70% of its reported portfolio and ranking #37 among its reported holdings. ARS Investment Partners, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)58.56K sh
Reported value held$15.50M
Portfolio Weight0.70%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How ARS Investment Partners, LLC's JNJ position evolved

ARS Investment Partners, LLC first disclosed a stake in JNJ in Q3 2023 at 44,239 shares (US$6.9M). The position peaked in Q3 2026 at 58,564 shares, worth US$15.5M. Across 13 filings, ARS Investment Partners, LLC increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 58,564 shares valued at US$15.5M — a reduction of -394 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 44.24K $6.89M New
Q4 2023 47.76K $7.49M Add
Q1 2024 48.43K $7.66M Add
Q2 2024 53.61K $7.84M Add
Q3 2024 52.24K $8.47M Reduce
Q4 2024 49.10K $7.10M Reduce
Q1 2025 48.15K $6.96M Reduce
Q2 2025 49.42K $7.55M Add
Q3 2025 49.25K $9.13M Hold
Q4 2025 56.98K $11.79M Add
Q1 2026 58.52K $14.30M Add
Q2 2026 58.96K $14.97M Add
Q3 2026 58.56K $15.50M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has ARS Investment Partners, LLC held JNJ?

ARS Investment Partners, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is ARS Investment Partners, LLC's current position in JNJ?

As of Q3 2026, ARS Investment Partners, LLC holds 58.56K shares of JNJ (JOHNSON & JOHNSON), valued at $15.50M, representing 0.70% of its reported portfolio and ranking #37.

Has ARS Investment Partners, LLC been buying or selling JNJ?

In the latest 13F filing (Q3 2026), ARS Investment Partners, LLC reduced its position in JNJ. The position peaked in Q3 2026 at 58.56K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.